IBJNews

WellPoint's third-quarter profits beat expectations

Back to TopCommentsE-mailPrintBookmark and Share

WellPoint Inc.’s third-quarter profits fell 11 percent, the company reported this morning, but still soared above analysts’ expectations.

WellPoint earned $1.53 per share, even after taking a 28-cent-per-share charge to write down the value of some assets. WellPoint also had 3 cents of investment gains during the quarter, which ended Sept. 30.

The Indianapolis-based health insurance giant's profit from the quarter totaled $730.2 million, down 11 percent from $820.7 million, or $1.60 per share, in the same period a year ago.

Wall Street analysts were expecting earnings of $1.38 per share, according to a survey by Thomson Reuters.

Revenue for the third quarter was $15.21 billion, down slightly but also slightly above analysts’ expectations of $15.15 billion.

In spite of beating analysts’ expectations and receiving some investment gains in the third quarter, WellPoint did not change its year-end profit forecast of $5.06 to $5.12 per share.

WellPoint CEO Angela Braly, in a statement, said the company is seeing higher medical usage due to a busier flu season and high numbers of unemployed workers using their COBRA insurance benefits.

“We are performing well as an organization in a difficult economic environment,” she said.

WellPoint lost 366,000 members in its health plans during the quarter. Its total customer base has shrunk by 4 percent in the past year.

WellPoint wrote down the value of its pharmacy benefits assets, which it has agreed to sell to St. Louis-based Express Scripts Inc. Also, it wrote down the value of its UniCare subsidiary because of expected membership declines next year.

ADVERTISEMENT

Post a comment to this story

COMMENTS POLICY
We reserve the right to remove any post that we feel is obscene, profane, vulgar, racist, sexually explicit, abusive, or hateful.
 
You are legally responsible for what you post and your anonymity is not guaranteed.
 
Posts that insult, defame, threaten, harass or abuse other readers or people mentioned in IBJ editorial content are also subject to removal. Please respect the privacy of individuals and refrain from posting personal information.
 
No solicitations, spamming or advertisements are allowed. Readers may post links to other informational websites that are relevant to the topic at hand, but please do not link to objectionable material.
 
We may remove messages that are unrelated to the topic, encourage illegal activity, use all capital letters or are unreadable.
 

Messages that are flagged by readers as objectionable will be reviewed and may or may not be removed. Please do not flag a post simply because you disagree with it.

Sponsored by
ADVERTISEMENT

facebook - twitter on Facebook & Twitter

Follow on TwitterFollow IBJ on Facebook:
Follow on TwitterFollow IBJ's Tweets on these topics:
 
Subscribe to IBJ
ADVERTISEMENT